Web Results

Vaso Active Pharmaceuticals, Inc., Debtors, Jeoffrey L. Burtch ...


Aug 11, 2014 ... FOR THE DISTRICT OF DELAWARE. In re: ) Chapter 11. ) VASO ACTIVE PHARMACEUTICALS, INC., ). ) Case No. 10-10855 (CSS). Debtors.

George L. Miller v. JNJ Logistics LLC - District of Delaware


Aug 14, 2014 ... In Re: : : PROLIANCE INTERNATIONAL, INC., et al. : Chapter 7 ...... this ruling in In re Vaso Active Pharmaceuticals, Inc.43 Therein, the.

Vaso Active Pharmaceuticals, Inc. : Lit. Rel. No. 18834 / August 17 ...


Aug 17, 2004 ... Litigation Release No. 18834 / August 17, 2004. SEC Files Settled Action Charging Vaso Active Pharmaceuticals, Inc. and its President and ...

Cases | A.B. Data Class Action Administration


Beverly Enterprises - Arkansas, Inc., et al. and Vera Cooney and Eula Mae Allen, et al., v. Beverly ...... In re Vaso Active Pharmaceuticals Securities Litigation.

New Value Does Not Need to Remain Unpaid. - Buchanan Ingersoll ...

www.bipc.com/files/Publication/ae486945-dfa3-4358-9609-fa2039dcc365/Presentation/PublicationAttachment/00f83896-756b-4d43-9913-1e12cab8692d/New Value Does Not Need to Remain Unpaid.pdf

Oct 29, 2014 ... In In re Proliance International, Inc., et al., Judge Sontchi of the United ... Design, Inc. and In re Vaso Active Pharmaceuticals, Inc., at lease by.

Vaso Active Pharmaceuticals, Inc.: OTCMKTS:VAPHQ quotes ...


Vaso Active Pharmaceuticals, Inc. is a company focused on commercializing, marketing and selling over-the-counter (OTC) pharmaceutical products. Vaso ...

Regulation of Dopamine Uptake by Vasoactive Peptides in the Kidney


Aug 22, 2016 ... Regulation of Dopamine Uptake by Vasoactive Peptides in the Kidney. N. L. Rukavina Mikusic, N. M. Kouyoumdzian, [...], and M. R. Choi.

Depolarization Increases Vasoactive Intestinal Peptide- and ...


ganglion (SCG) of the adult rat (Hokfelt et al., 1977; Sasek and. Zigmond, 1989). ... synthesis, depolarization of sympathetic neurons has been re- ported to inhibit the .... by adding 1.5 PM veratridine (ICN Pharmaceuticals Inc., Plainview,. NY).

VPAC1 receptor expression in peripheral blood mononuclear cells ...


May 7, 2013 ... Vasoactive intestinal peptide (VIP) has a broad range of biological actions such ... A and Buffer B according the protocol (Phoenix Pharmaceuticals Inc., Karlsruhe, .... It is likely that receptor internalization as described by Langlet et al., [27] is ... As suggested previoulsy [27], recycling and re-organization of ...

Vasoactive Exposures during Pregnancy and Risk of Microtia - NCBI


Nov 24, 2012 ... Risk estimates for vasoactive medications and smoking were not .... Drugs are coded using the Boston University Slone Epidemiology Center Drug Dictionary ( Kelley et al., ..... and the company makes a number of the products under study; the .... [PubMed]; Stevenson RE, Burton OM, Ferlauto GJ, Taylor HA.